Table 1. Demographic data for men and women.
| Men | Women | P value | ||
| All subjects (%) | 2395 (49.8%) | 2419 (50.2%) | ||
| Age (years) | 59.5±7.8 | 59.6±7.8 | ||
| Known CAD | 259 (10.8%) | 68 (2.8%) | ||
| Subjects without CAD | 2136 (89.2%) | 2351 (97.2%) | ||
| Stroke | 3.0% | 1.8% | 0.01 | |
| Glucose (mg/dL) | 114.7±30.3 | 107.1±23.2 | <0.0001 | |
| Glycosylated hemoglobin (%) | 5.6±0.9 | 5.4±0.8 | <0.0001 | |
| < 6.5% | 90.4% | 93.9% | < 0.0001 | |
| ≥ 6.5 - 7.5% | 5.6% | 3.6% | ||
| ≥ 7.5% | 4.0% | 2.5% | ||
| Known diabetes | 9.3% | 6.3% | 0.0002 | |
| Known hypertension | 42.9% | 40.2% | 0.07 | |
| RR systolic (mm Hg) | 138.1±19.3 | 128.3±21.0 | < 0.0001 | |
| RR diastolic (mm Hg) | 84.5±10.5 | 79.0±10.5 | < 0.0001 | |
| Normal/borderline hypertension | 53.6% | 69.2% | < 0.0001 | |
| Stage 1: 140-159 / 90-99 mm Hg | 31.1% | 22.3% | ||
| Stage 2: ≥160 / ≥ 100 mm Hg | 15.2% | 8.5% | ||
| Non-smokers | 29.3% | 56.0% | < 0.0001 | |
| Ex-smokers | 44.7% | 22.7% | ||
| Smokers | 26.0% | 21.3% | ||
| BMI (kg/m2) | 28.2±4.0 | 27.6±5.2 | < 0.0001 | |
| BMI ≥ 25 kg/m2 | 80.8% | 65.6% | < 0.0001 | |
| BMI ≥ 30 kg/m2 | 26.2% | 28.1% | 0.16 | |
| Known hypercholesterolemia | 50.5% | 49.5% | 0.50 | |
| Total cholesterol (TC) (mg/dL) | 227.7±37.7 | 234.2-39.4 | < 0.0001 | |
| TC | < 200 mg/dl | 22.4% | 18.5% | < 0.0001 |
| ≥ 200-239 mg/dL | 41.9% | 38.7% | ||
| ≥ 240 mg/dL | 35.7% | 42.8% | ||
| HDL (mg/dL) | 51.5±14.4 | 65.1±17.0 | < 0.0001 | |
| Non-HDL (mg/dL) | 176.2±38.4 | 169.0±40.5 | < 0.0001 | |
| LDL (mg/dL) | 147.3±35.2 | 146.5±36.8 | 0.40 | |
| LDL | < 130 mg/dl | 30.8% | 33.4% | 0.88 |
| ≥ 130-159 mg/dL | 34.9% | 31.6% | ||
| ≥ 160-189 mg/dL | 23.6% | 23.0% | ||
| ≥ 190 mg/dL | 10.7% | 12.0% | ||
| Triglycerides (TG) (mg/dL) | 165.5±120.2 | 132.5±77.3 | < 0.0001 | |
| TG | < 150 mg/dl | 55.9% | 70.8% | < 0.0001 |
| ≥ 150-199 mg/dL | 18.6% | 15.8% | ||
| ≥ 200-499 mg/dL | 23.9% | 13.0% | ||
| ≥ 500 mg/dL | 1.6% | 0.4% | ||
| FRS (% over 10 years) | 15.8±9.5 | 7.6±4.9 | < 0.0001 | |
| FRS | < 10% over 10 years | 30.8% | 74.1% | < 0.0001 |
| ≥ 10 - ≤ 20% over 10 years | 43.0% | 24.5% | ||
| > 20% over 10 years | 26.2% | 1.4% | ||
| hs CRP (Median, mg/L) | 1.3 | 1.4 | 0.20 | |
| hs CRP | ≤1 mg/L | 40.8% | 38.4% | 0.09 |
| > 1 - ≤ 3 mg/L | 37.3% | 38.1% | ||
| > 3 - ≤ 10 mg/L | 21.9% | 23.5% | ||
| Degree of calcification (Agatston score) Median | 55.2 | 1.5 | < 0.0001 | |
| 0-99 | 59.6% | 84.6% | < 0.0001 | |
| ≥ 100-399 | 23.6% | 10.9% | ||
| ≥ 400 | 16.8% | 4.5% | ||
| 0 | 17.7% | 44.8% | < 0.0001 | |
| > 0 and < 75th percentile | 57.4% | 30.3% | ||
| ≥ 75th percentile | 24.9% | 24.9% | ||
Mean ± standard deviation, or percent, for various risk factors associated with cardiovascular disease; table also includes Framingham risk scores (FRS) and degree of coronary calcification (Agatston score).
CAD, coronary artery disease; RR, blood pressure (Riva Rocci method); BMI, body mass index; HDL, high-density lipoprotein; LDL, light-density lipoprotein; FRS, Framingham risk score calculated according to (18); hs CRP, high-sensitive C-reactive protein. P values for gender differences.